Advair Diskus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD
Condition:   Chronic Obstructive Pulmonary Disease (COPD)Interventions:   Drug: QVA149;   Drug: Tiotropium;   Drug: Salmeterol/fluticasoneSponsor:   Novartis PharmaceuticalsNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2015 Category: Research Source Type: clinical trials